7World Health Organization. Sensitivity testing of Neisseria gonorrhoeae : methodologies for use by participants in the WHO Western Pacific Regional Resistance Surveillance Programme [ J ]. WHO/WPR Regional Antimicrobial Surveillance Working Group Meeting Proceedings, 1992. 33-34.
8Reinthaler FF, Posch J, Feierl G. Antibiotic resistance of E.coli in sewage and sludge[J]. Water Research, 2003, 37:1685.
9Kummerer K. Resistance in the environment[J]. Journal of Antimicrobial Chemotherapy,2004,54:311.
10Malakoff David. Microbiologists on the trail of polluting bacteria[J]. Science, 2002,29 : 2352.
6Weiser T G, Regenbogen S E, Thompson K D, et al. An estima- tion of the global volume of surgery: a modelling strategy based on available data[J]. Lancet, 2008, 372(9633):139--144.
7Gawande A A, Thomas E J, Zinner M J, et al. The incidence and nature of surgical adverse events in Colorado and Utah in 1992 [J]. Surgery, 1999,126(1) :66--75.
8Kable A K, Gibberd R W, Spigelman A D. Adverse events in sur gical patients in Australia [J].Int J Qual Health Care, 2002,14 (4) :269--176.
9Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event AS of June30[EB/OL]. (2006--12--29) [2011--05-- 10]. http,//www, jointcommission, org/.
10De Vries EN, Ramrattan M A, Smorenburg S M, et al. The incidence and nature of in-- hospital adverse events: a systematic re view[J]. QualSafHealthCare, 2008,17(3):216--223.
